Sujet(s)
Maladie d'Ebstein/imagerie diagnostique , Cardiopathies congénitales/imagerie diagnostique , Défaillance cardiaque/imagerie diagnostique , Défaillance cardiaque/chirurgie , Dispositifs d'assistance circulatoire , Imagerie multimodale/méthodes , Adolescent , Maladie d'Ebstein/complications , Échocardiographie-doppler/méthodes , Électrocardiographie/méthodes , Service hospitalier d'urgences , Études de suivi , Cardiopathies congénitales/complications , Défaillance cardiaque/étiologie , Humains , Mâle , Sortie du patient , Radiographie thoracique/méthodes , Appréciation des risques , Indice de gravité de la maladie , Résultat thérapeutiqueRÉSUMÉ
The 1971 preliminary criteria for the classification of systemic lupus erythematosus (SLE) were revised and updated to incorporate new immunologic knowledge and improve disease classification. The 1982 revised criteria include fluorescence antinuclear antibody and antibody to native DNA and Sm antigen. Some criteria involving the same organ systems were aggregated into single criteria. Raynaud's phenomenon and alopecia were not included in the 1982 revised criteria because of low sensitivity and specificity. The new criteria were 96% sensitive and 96% specific when tested with SLE and control patient data gathered from 18 participating clinics. When compared with the 1971 criteria, the 1982 revised criteria showed gains in sensitivity and specificity.